DO-BO

The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff (Repost)

This is a repost of a popular episode of MAP – Market Access Podcast, from December 1st 2023.

We are thrilled to announce our latest podcast episode, featuring a riveting conversation between our CEO Dr. Stefan Walzer and the esteemed healthcare reimbursement expert, Ron de Graaff. 

Ron, with his deep-rooted experience starting from 1978, shares his invaluable insights on the evolution of healthcare reimbursement, a journey from simpler times to today’s intricate landscape involving multiple stakeholders like health insurance companies.

🔍 Key Highlights:

– Ron’s path from founding his company in 1985, which has since assisted over 900 entities, including governments, in understanding medical technology markets.

– Challenges faced by startups in healthcare, often led by technical experts who struggle with the language and complexities of reimbursement processes.

– The criticality of startups understanding both the payer perspectives and the changing requirements of reimbursement systems across Europe.

– Ron’s advice to startups: comprehensively understand the reimbursement system of your target market and assess if your product is likely to be reimbursable.

This episode is a must-listen for anyone in the healthcare industry, particularly startups navigating the daunting world of reimbursement. Expect to gain a thorough understanding of how to strategically plan for reimbursement, the importance of being updated with current regulations, and how to choose the right market for your product.

Related

By the time most health economists get pulled in, the recipe is already set. In this episode of MAP — the Market Access Podcast, Dr. Stefan Walzer sits down with two industry veterans — Dr. Björn Schwander, Founder of AHEAD GmbH and a specialist in early health economic modeling, and Julie Frappier, senior health economist […]

This is a repost of a popular episode of MAP – Market Access Podcast, from March 1st 2025. In this episode of MAP, Dr. Stefan Walzer, together with experts Douglas Drake and Adam Skali, unpacks the complexities of how GDPR regulations affect real-world evidence, cross-border studies, and market access in Europe. The discussion highlights data […]

In the latest episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Dr. Alexander Natz, Secretary-General of EUCOPE, to unpack the biggest regulatory shifts reshaping pharmaceutical market access across Europe right now. They discuss how the EU Joint Clinical Assessment (JCA) now starts national HTA timelines as soon as a […]